MMA: A Byproduct of B12-Dependent Mitochondrial Metabolism
Methylmalonic acid (MMA) is a small organic acid your body produces while breaking down certain proteins and fats. It forms inside mitochondria during the propionate pathway, where fragments from odd-chain fatty acids and specific amino acids are converted toward energy use. A vitamin B12–dependent enzyme normally channels these fragments from methylmalonyl-CoA to succinyl-CoA; when that step is limited, methylmalonyl-CoA is diverted to MMA, which appears in the bloodstream. An MMA blood test measures the amount of this metabolic byproduct in blood.
MMA matters because it mirrors the activity of a single, B12-dependent metabolic step inside cells. The enzyme methylmalonyl-CoA mutase requires active vitamin B12 (adenosylcobalamin), so MMA reflects intracellular B12 function and the integrity of the pathway that feeds carbon units into succinyl-CoA and the energy-producing TCA cycle. MMA levels are also influenced by how well the kidneys clear this acid and by rare inherited defects in this enzyme system. In short, MMA serves as a sensitive readout of B12-driven mitochondrial metabolism.
Why MMA Catches B12 Deficiency Earlier Than Serum B12
Methylmalonic acid (MMA) is a small molecule made during the breakdown of certain amino acids and fats. It rises when a B12-dependent enzyme in mitochondria stalls, so it's a sensitive readout of vitamin B12 function inside cells. Because B12 underpins red blood cell formation, nerve myelin, and DNA synthesis, MMA helps explain fatigue, neuropathy, and cognitive changes across body systems.
This makes MMA a sensitive indicator of intracellular B12 status, linking to energy production (TCA cycle), myelin integrity and nerve function, red blood cell DNA synthesis, cognition, and healthy pregnancy. MMA is also cleared by the kidneys, so renal function influences levels.
Reading an MMA Result From Low to High
Most labs consider MMA normal when it's below about 0.4, and the healthiest results tend to sit toward the low end of the range. Kidney function, age, and pregnancy can shift where a given value sits.
Values on the low side generally mean efficient mitochondrial metabolism and adequate cellular B12. People feel well, blood counts stay stable, and nerves conduct normally. Low or undetectable MMA is expected in healthy children and adults and is not a concern. They are common in younger adults and generally have no adverse physiological implications.
Being in range suggests adequate intracellular B12, intact mitochondrial propionate oxidation, and stable hematologic and neurologic function. In practice, risk of B12-related problems increases as MMA drifts toward the upper end of normal; "within reference ranges" typically sits in the lower to mid-range if kidney function is normal.
Higher values suggest a functional B12 deficiency or reduced renal clearance. When elevated due to B12 lack, people may notice tiredness, pallor, shortness of breath, sore tongue, numbness or tingling, balance problems, and memory or mood changes, reflecting effects on marrow, nerves, and brain. In older adults and those with kidney disease, MMA can rise from impaired excretion. During pregnancy, mild increases may occur even with adequate B12. In infants and young children, very high levels can indicate rare inborn errors of metabolism.
Physiologically, impaired methylmalonyl-CoA mutase activity leads to MMA accumulation, with system-level effects such as fatigue, paresthesias and gait changes (peripheral neuropathy), cognitive slowing, and megaloblastic anemia risk. Medications and conditions that impair B12 absorption or utilization (e.g., metformin, nitrous oxide exposure, gastric surgery, pernicious anemia) can elevate MMA.
Kidney Function, Age, and Pregnancy Can Shift MMA
Interpretation should consider age, pregnancy, and kidney function. Assay methods vary slightly. Newborns can have higher MMA. Very high values occur in rare inherited methylmalonic acidemias. Levels also rise with reduced kidney function, advanced age, and in pregnancy (especially late gestation).
Pairing MMA With B12 and Homocysteine
MMA pairs clinically with serum B12 or holotranscobalamin and homocysteine to clarify cobalamin status and distinguish B12 deficiency from folate deficiency.
What MMA Adds to the B12 Picture
Big picture, MMA complements serum B12 and homocysteine to pinpoint intracellular B12 status and intersects with hematologic, neurologic, and renal systems. Persistently high MMA flags risk for anemia and nerve injury and, in pregnancy and early life, developmental concerns.
FAQs
Methylmalonic acid (MMA) is a small organic acid produced in mitochondria during the breakdown of certain amino acids and odd-chain fats. Its conversion to succinyl-CoA depends on vitamin B12 (adenosylcobalamin) and the enzyme methylmalonyl-CoA mutase. MMA serves as a sensitive marker for cellular B12 status because it accumulates when B12 is deficient or the enzyme is impaired. Elevated MMA can indicate early, tissue-level B12 deficiency before anemia or nerve damage develops, making it a valuable tool for evaluating and monitoring B12-related health issues.
MMA testing is crucial for distinguishing between vitamin B12 and folate deficiency because only B12 deficiency causes MMA to rise. Both deficiencies can present with similar blood count abnormalities, such as macrocytic anemia, but folate deficiency does not increase MMA levels. Instead, folate deficiency raises homocysteine. Therefore, measuring MMA alongside homocysteine and serum B12 helps clarify the underlying cause of symptoms and guides appropriate supplementation.
Doctors may order an MMA test when patients present with unexplained fatigue, numbness, tingling, memory issues, or macrocytic anemia—symptoms that can result from cellular B12 deficiency. MMA testing is also used when serum B12 levels are borderline or when symptoms persist despite normal B12 results. It is particularly valuable for individuals at risk of B12 deficiency, such as older adults, pregnant women, vegans, those on metformin or acid reducers, and patients with a history of bariatric surgery.
MMA levels are best interpreted alongside kidney function tests, serum B12, holotranscobalamin, and homocysteine. Since MMA is cleared by the kidneys, reduced renal function can cause MMA to rise independently of B12 status. High MMA with normal kidney function usually indicates B12 deficiency, while elevated MMA with impaired kidney function may reflect reduced clearance. Combining these markers helps clarify the cause of abnormal results and guides targeted treatment.
Most laboratories consider MMA values below 0.40 μmol/L as within the normal range, with within reference ranges status tending toward the lower end. Low MMA reflects efficient B12-dependent metabolism and good kidney clearance, indicating adequate B12 supply. High MMA usually signals functional B12 deficiency at the tissue level, even if serum B12 is normal, or reduced kidney filtration. Marked elevations may also suggest rare inherited metabolic disorders, especially in infants.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Stabler, S. P. (2013). Clinical practice. Vitamin B12 deficiency. The New England Journal of Medicine, 368(2), 149-160. https://doi.org/10.1056/NEJMcp1113996
- Smith, A. D., & Refsum, H. (2021). Homocysteine - from disease biomarker to disease prevention. Journal of Internal Medicine, 290(4), 826-854. https://doi.org/10.1111/joim.13279
- Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., 3rd, Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., Molloy, A. M., Caudill, M. A., Shane, B., Berry, R. J., Bailey, R. L., Hausman, D. B., Raghavan, R., & Raiten, D. J. (2015). Biomarkers of Nutrition for Development-Folate Review. The Journal of Nutrition, 145(7), 1636S-1680S. https://doi.org/10.3945/jn.114.206599
- Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998). Homocysteine and cardiovascular disease. Annual Review of Medicine, 49, 31-62. https://doi.org/10.1146/annurev.med.49.1.31
- National Institutes of Health, Office of Dietary Supplements. (2022). Folate: Fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/






































.avif)
